Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.59% |
| 2 | Technology | 20.43% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Healthcare | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Applied Materials
AMAT
$325B
| $1.47B | 0.11% |
10,149,089
-872,706
| -8% | -$147M |
2013 Q2
47 quarters
|
|
177
iShares MSCI Japan ETF
EWJ
$23.1B
| $1.47B | 0.1% |
21,380,037
-418,136
| -2% | -$28.8M |
2013 Q2
47 quarters
|
|
178
ICICI Bank
IBN
$108B
| $1.45B | 0.1% |
46,021,744
+312,159
| +0.7% | +$9.06M |
2013 Q2
47 quarters
|
|
179
Vanguard Intermediate-Term Treasury ETF
VGIT
$40B
| $1.42B | 0.1% |
23,931,107
+1,423,868
| +6% | +$83.3M |
2013 Q2
47 quarters
|
|
180
Emerson Electric
EMR
$90.1B
| $1.41B | 0.1% |
12,849,326
-681,291
| -5% | -$82.1M |
2013 Q2
47 quarters
|
|
181
Welltower
WELL
$169B
| $1.41B | 0.1% |
9,182,678
+2,108,196
| +30% | +$300M |
2013 Q2
47 quarters
|
|
182
Duke Energy
DUK
$94.7B
| $1.4B | 0.1% |
11,510,256
+322,685
| +3% | +$36.8M |
2013 Q2
47 quarters
|
|
183
iShares Gold Trust
IAU
$61.8B
| $1.4B | 0.1% |
23,783,416
+293,391
| +1% | +$15.9M |
2013 Q2
47 quarters
|
|
184
Pacer US Cash Cows 100 ETF
COWZ
$19.5B
| $1.39B | 0.1% |
25,308,444
-2,552,224
| -9% | -$145M |
2018 Q3
26 quarters
|
|
185
Micron Technology
MU
$994B
| $1.38B | 0.1% |
15,878,654
-722,604
| -4% | -$69.4M |
2013 Q2
47 quarters
|
|
186
iShares MSCI Emerging Markets ETF
EEM
$29.1B
| $1.37B | 0.1% |
31,303,247
-6,640,661
| -18% | -$288M |
2013 Q2
47 quarters
|
|
187
Alibaba
BABA
$271B
| $1.35B | 0.1% |
10,209,362
-1,932,871
| -16% | -$223M |
2014 Q3
42 quarters
|
|
188
Trip.com Group
TCOM
$25.2B
| $1.34B | 0.1% |
21,072,701
-985,166
| -4% | -$64.5M |
2013 Q2
47 quarters
|
|
189
Otis Worldwide
OTIS
$27.2B
| $1.33B | 0.1% |
12,893,365
+966,988
| +8% | +$94.5M |
2020 Q2
19 quarters
|
|
190
Parker-Hannifin
PH
$121B
| $1.33B | 0.1% |
2,184,988
-83,524
| -4% | -$54.6M |
2013 Q2
47 quarters
|
|
191
Vanguard FTSE All-World ex-US ETF
VEU
$67B
| $1.31B | 0.09% |
21,546,583
-384,797
| -2% | -$23.2M |
2013 Q2
47 quarters
|
|
192
Vanguard Short-Term Treasury ETF
VGSH
$35.2B
| $1.31B | 0.09% |
22,253,932
+384,001
| +2% | +$22.4M |
2013 Q2
47 quarters
|
|
193
Sempra
SRE
$54.5B
| $1.3B | 0.09% |
18,259,653
-4,263,351
| -19% | -$332M |
2013 Q2
47 quarters
|
|
194
Amphenol
APH
$196B
| $1.3B | 0.09% |
39,530,254
-233,406
| -0.6% | -$7.96M |
2013 Q2
47 quarters
|
|
195
Elevance Health
ELV
$92.9B
| $1.29B | 0.09% |
2,973,109
+104,911
| +4% | +$42.1M |
2013 Q2
47 quarters
|
|
196
Royalty Pharma
RPRX
$27.1B
| $1.28B | 0.09% |
41,029,832
+1,497,062
| +4% | +$47.5M |
2020 Q2
19 quarters
|
|
197
Vanguard High Dividend Yield ETF
VYM
$81.6B
| $1.28B | 0.09% |
9,899,748
+150,975
| +2% | +$19.8M |
2013 Q2
47 quarters
|
|
198
Energy Transfer Partners
ET
$69.8B
| $1.28B | 0.09% |
68,630,159
-24,014,555
| -26% | -$468M |
2013 Q2
47 quarters
|
|
199
GE Vernova
GEV
$245B
| $1.27B | 0.09% |
4,171,365
-290,657
| -7% | -$101M |
2024 Q1
4 quarters
|
|
200
Nu Holdings
NU
$70.3B
| $1.27B | 0.09% |
124,223,839
+6,130,207
| +5% | +$72.4M |
2021 Q4
13 quarters
|
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 407 new, 3,433 increased, 3,304 reduced and 268 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 407 new positions and closed 268 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.